title: Phase II study of navelbine in advanced renal cell carcinoma.
authors.forename: L
authors.initials: L
authors.lastname: Canobbio
authors.forename: F
authors.initials: F
authors.lastname: Boccardo
authors.forename: D
authors.initials: D
authors.lastname: Guarneri
authors.forename: C
authors.initials: C
authors.lastname: Calabria
authors.forename: A
authors.initials: A
authors.lastname: Decensi
authors.forename: A
authors.initials: A
authors.lastname: Curotto
authors.forename: G
authors.initials: G
authors.lastname: Martorana
authors.forename: L
authors.initials: L
authors.lastname: Giuliani
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine